≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Ankylosing hyperostosis [Forestier]

DOID EFO MESH SNOMED PheWeb

M13_FORESTIER

diffuse idiopathic skeletal hyperostosis: This syndrome is characterized by the association of ankylosing vertebral hyperostosis with hyperkeratosis of the soles and palms.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 M48.1
Hospital discharge: ICD-9 7216
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 M48.1
Cause of death: ICD-9 7216
Cause of death: ICD-8 $!$

324

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

324

diagram downward connector

Check minimum number of events None

324

diagram downward connector

Include endpoints None

324

diagram downward connector
M13_FORESTIER

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 M48
Name in latin Hyperostosis ancylopoetica

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 324 140 184
Unadjusted prevalence (%) 0.09 0.07 0.12
Mean age at first event (years) 58.49 57.51 59.24

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: M13_FORESTIER – Ankylosing hyperostosis [Forestier]
GWS hits: 1

Survival analyses between endpoints

↥

Plot

before Ankylosing hyperostosis [Forestier]
after Ankylosing hyperostosis [Forestier]

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Ankylosing hyperostosis [Forestier]

↥